OGN:NYSE
Organon & Co
13,72 $
arrow_upward
+0,07%(+0,010) 1D
13,72 $
0,00% (0,00)
bedtimeAfter hours
Closed: 2 қаз., 16:00:06 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
13,71 $
High
13,75 $
Low
13,71 $
Mkt. cap
3,60 млрд
Avg. vol.
2,83 млн
Volume
1,92 млн
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
2026 ж. 14 там.
P/E ratio
17,58
52-wk high
13,78 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 млн
No. of employees
10 мың
Open
13,71 $
High
13,75 $
Low
13,71 $
Mkt. cap
3,60 млрд
Avg. vol.
2,83 млн
Volume
1,92 млн
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
2026 ж. 14 там.
P/E ratio
17,58
52-wk high
13,78 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 млн
No. of employees
10 мың
News stories
From web sources and news partners
AD HOC NEWS
·
2 сағат бұрын
Organon stock presents new VTAMA analysis ahead of November results
Stock Traders Daily
·
1 күн бұрын
Behavioral Patterns of OGN and Institutional Flows
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 мың
Founded1923
HeadquartersДжерсей Сити, Нью-Джерси, Америка Құрама Штаттары
SectorPharmaceutical industry
Websiteorganon.com